Phase
Condition
Warts
Scalp Disorders
Psoriasis And Psoriatic Disorders
Treatment
Vitamin D3
Placebo
Triamcinolone
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18 and older
Mild to severe plaque psoriasis (2% or greater Body Surface Area; Psoriasis Area andSeverity Score of 2 or greater; Investigator Grade Assessment of mild-severe)
Exclusion
Exclusion Criteria:
Currently taking medication that alters the normal ion balance of low-dose in blood.
No calcium supplements 1 month prior to baseline (not including multivitamins).
Unstable or uncontrolled illness, including but not limited tocerebro-cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine,hematologic, neurologic or psychiatric disease at screening.
Abnormal laboratory values at screening, that in the opinion of the investigator,would potentially affect patient safety or data integrity.
Not on systemic non-biologic therapy (including, but not limited to, oral psoralenplus ultraviolet A [photochemotherapy (PUVA)] light therapy; cyclosporine;corticosteroids; methotrexate; oral retinoids; apremilast; tofacitinib;mycophenolate mofetil; thioguanine; hydroxyurea; sirolimus; tacrolimus;azathioprine; leflunomide; fumaric acid derivatives; or 1, 25 dihydroxy vitamin D3and analogues) within 28 days prior to baseline.
No phototherapy (including either oral and topical PUVA light therapy, ultravioletB, excimer laser, or self-treatment with tanning beds or therapeutic sunbathing)within 28 days prior to baseline.
No topical treatment (including, but not limited to, corticosteroids [upper midstrength or lower potency topical steroids are permitted on the intertriginous areasand face], crisaborole, anthralin, calcipotriene, topical vitamin D derivatives,retinoids, tazarotene, pimecrolimus, tacrolimus, emollients and othernonprescription topical products containing urea, >3% salicylic acid, alpha- orbeta-hydroxyl acids, or medicated shampoos [for example those that contain >3%salicylic acid, corticosteroids, coal tar, or vitamin D3 analogues]) within 14 daysprior to baseline.
No biologic agents within 8 weeks or three half-lives, whichever is greater prior tobaseline.
History of renal impairment.
History of renal stones.
History of parathyroid abnormalities
Osteoporosis
History of severe arthritis
Ongoing use of tanning bed or other UV device or excessive sunlight
Unable to understand/complete informed consent.
Study Design
Connect with a study center
Wright State Physicians
Fairborn, Ohio 45324
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.